| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 1.909 | 3.579 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Total Income - EUR | 1.909 | 3.635 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Total Expenses - EUR | 5.983 | 32.621 | 7.587 | 538 | 651 | 291 | 263 | 264 | 121 | - |
| Gross Profit/Loss - EUR | -4.074 | -28.986 | -7.586 | -538 | -651 | -291 | -263 | -264 | -121 | - |
| Net Profit/Loss - EUR | -4.132 | -29.077 | -7.586 | -538 | -651 | -291 | -263 | -264 | -121 | - |
| Employees | 1 | 3 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | - |
Check the financial reports for the company - Needle & Ink Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.183 | 2.102 | 1.779 | 1.464 | 1.159 | 1.114 | 1.089 | 1.093 | 1.089 | - |
| Current Assets | 814 | 130 | 150 | 138 | 151 | 148 | 145 | 145 | 145 | - |
| Inventories | 542 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Receivables | 45 | 64 | 150 | 142 | 140 | 137 | 134 | 134 | 134 | - |
| Cash | 227 | 66 | 0 | -5 | 11 | 11 | 11 | 11 | 11 | - |
| Shareholders Funds | -8.971 | -37.956 | -44.901 | -44.614 | -44.401 | -43.851 | -43.141 | -43.539 | -43.528 | - |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | - |
| Debts | 10.968 | 40.377 | 46.829 | 46.216 | 45.711 | 45.113 | 44.375 | 44.777 | 44.762 | - |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "9609 - 9609" | |||||||||
| CAEN Financial Year |
9609
|
|||||||||
Comments - Needle & Ink Srl